ProShare Advisors LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$209,535
-19.4%
26,967
+0.4%
0.00%0.0%
Q2 2023$260,072
-7.6%
26,867
+4.7%
0.00%0.0%
Q1 2023$281,376
+124.5%
25,673
-11.5%
0.00%
Q4 2022$125,340
-38.0%
29,014
+8.6%
0.00%
-100.0%
Q3 2022$202,000
-22.9%
26,724
+2.4%
0.00%0.0%
Q2 2022$262,000
+44.8%
26,104
+78.1%
0.00%
Q1 2022$181,000
-56.7%
14,660
-19.7%
0.00%
-100.0%
Q4 2021$418,000
-31.1%
18,261
-33.4%
0.00%
-50.0%
Q3 2021$607,000
+103.7%
27,429
+19.1%
0.00%
+100.0%
Q2 2021$298,000
+30.1%
23,027
+30.6%
0.00%0.0%
Q1 2021$229,000
-15.2%
17,633
-9.7%
0.00%0.0%
Q4 2020$270,000
-10.0%
19,533
-4.0%
0.00%0.0%
Q3 2020$300,000
+2.7%
20,345
+13.0%
0.00%
-50.0%
Q2 2020$292,000
+36.4%
17,998
+21.9%
0.00%0.0%
Q1 2020$214,000
-48.2%
14,763
-27.6%
0.00%0.0%
Q4 2019$413,000
+210.5%
20,397
-17.9%
0.00%
+100.0%
Q3 2019$133,000
-24.9%
24,850
-7.4%
0.00%0.0%
Q2 2019$177,000
-5.9%
26,829
-7.4%
0.00%0.0%
Q1 2019$188,000
-4.6%
28,985
+0.2%
0.00%0.0%
Q4 2018$197,000
-13.6%
28,923
-15.8%
0.00%
-50.0%
Q3 2018$228,000
+14.6%
34,338
-3.0%
0.00%
+100.0%
Q2 2018$199,000
-1.5%
35,384
-8.9%
0.00%0.0%
Q1 2018$202,000
+55.4%
38,861
+35.0%
0.00%0.0%
Q4 2017$130,00028,7830.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders